OS Therapies Inc. - OSTX Sotuvning sof marjinal rentabelligi

OS Therapies (OSTX) tovar belgisi

Kirish uchun yuqori to'siqlar patent himoyasi va R&D xarajatlari bilan bog'liq. OS Therapies Incorporated (OSTX) maqsadli suyak saratoni terapiyalarini ishlab chiqish uchun berilgan grantlar asosida daromad keltiradi. Biznes muvaffaqiyati vaksina sinovlariga va FDA qaroriga bog'liq. Bashorat qilingan savdo marjalari joriy xarajatlarni boshqarish samaradorligini ko'rsatadi, bunda ko'rsatkich 0.00 darajasida bo'lib, bu bozor konsensusini belgilaydi.

OS Therapies Incorporated (OSTX) - Sof marja 02.08.2024dan 20.11.2026gacha

OSTX (OS Therapies, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning umumiy tahlili:OS Therapies Inc. - OSTX
OS Therapies Inc yetakchi tovari

Portfel tahlilchisi biofarmatsevtika sektoridagi fundamental jihatdan barqaror aktivlarni saralash uchun ushbu ko'rsatkichdan foydalanadi. Ushbu metrika har bir dollar daromadning sof foyda ulushini o'lchab, bozor shovqinlarini bartaraf etadi. OS Therapies Incorporated (OSTX) uchun hisob-kitoblar vaksina ishlab chiqarishni CDMO bio-fabrikalariga autsorsing qilish samaradorligini aks ettiradi. Bu kapital xarajatlarni minimallashtiradi, natijada operatsion pul oqimini barqarorlashtiradi. Operatsion sof savdo marjalarining tahlili biznesning tashqi zarbalarga nisbatan haqiqiy barqarorligini aniqlash imkonini beradi.

OS Therapies Incorporated (OSTX) raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)